Progesterone to Estrogen Ratio Calculator
Free Progesterone estrogen ratio Calculator with medically-sourced formulas. Enter your measurements for personalized, accurate health insights.
Formula
Pg/E2 Clinical Ratio = (Progesterone ng/mL / Estradiol pg/mL) x 1000
Where progesterone is measured in ng/mL (or converted from nmol/L by dividing by 3.18) and estradiol is measured in pg/mL (or converted from pmol/L by dividing by 3.671). The multiplication by 1000 normalizes the ratio for clinical interpretation. Optimal luteal phase ratio is typically 100-500.
Worked Examples
Example 1: Mid-Luteal Phase Assessment
Problem: A woman has a day 21 blood test showing progesterone of 15 ng/mL and estradiol of 150 pg/mL. Calculate the Pg/E2 ratio and assess luteal phase adequacy.
Solution: Clinical Ratio = (Progesterone ng/mL / Estradiol pg/mL) x 1000\nClinical Ratio = (15 / 150) x 1000 = 100\nSame-unit ratio (both in pg/mL): 15,000 / 150 = 100:1\nLuteal phase optimal range: 100-500\nProgesterone >10 ng/mL confirms ovulation\nResult: Ratio of 100 is at the lower end of normal luteal range
Result: Pg/E2 Ratio: 100 - Normal range, confirms ovulation with adequate luteal progesterone
Example 2: Suspected Estrogen Dominance
Problem: A woman with PMS symptoms has progesterone of 4 ng/mL and estradiol of 180 pg/mL on day 21. Evaluate the ratio.
Solution: Clinical Ratio = (4 / 180) x 1000 = 22.2\nSame-unit ratio: 4,000 / 180 = 22.2:1\nLuteal phase optimal range: 100-500\nRatio of 22.2 is well below the optimal range\nProgesterone of 4 ng/mL is below the 10 ng/mL threshold for confirmed ovulation\nThis suggests possible anovulation or luteal phase defect
Result: Pg/E2 Ratio: 22.2 - Estrogen Dominant. Low progesterone suggests anovulatory cycle or luteal phase deficiency
Frequently Asked Questions
What is the progesterone to estrogen ratio and why is it clinically important?
The progesterone to estrogen ratio (Pg/E2 ratio) measures the relative balance between these two primary female sex hormones, which work in opposition to maintain reproductive health and hormonal homeostasis. This ratio is clinically significant because many symptoms attributed to hormone imbalance result not from absolute levels of either hormone alone but from their relative proportions. Estrogen dominance, where estrogen is relatively high compared to progesterone, has been associated with conditions including premenstrual syndrome, fibrocystic breasts, endometriosis, heavy menstrual bleeding, and increased risk of certain hormone-sensitive cancers. Monitoring this ratio helps clinicians evaluate ovulatory function, luteal phase adequacy, and the effectiveness of hormone replacement therapy.
What are the normal progesterone to estrogen ratio ranges for different phases of the menstrual cycle?
The optimal Pg/E2 ratio varies significantly across the menstrual cycle because both hormones fluctuate dramatically throughout each phase. During the follicular phase (days 1-13), progesterone is very low (0.2-1.5 ng/mL) while estradiol rises gradually, producing a low ratio. At ovulation, estradiol peaks at 150-400 pg/mL while progesterone just begins to rise, creating the lowest ratio of the cycle. During the luteal phase (days 15-28), progesterone surges to 5-20 ng/mL while estradiol moderates to 40-200 pg/mL, producing the highest ratio. A clinical ratio (Pg ng/mL divided by E2 pg/mL times 1000) of 100-500 during the mid-luteal phase generally indicates adequate progesterone production and successful ovulation.
What causes estrogen dominance and what are its symptoms?
Estrogen dominance occurs when estrogen levels are disproportionately high relative to progesterone, even if absolute estrogen levels appear normal. Common causes include anovulatory cycles where no corpus luteum forms to produce progesterone, chronic stress which diverts progesterone precursors toward cortisol production, obesity (adipose tissue produces estrogen through aromatase activity), exposure to xenoestrogens in plastics and personal care products, and impaired estrogen metabolism in the liver. Symptoms may include heavy or irregular periods, breast tenderness, bloating, mood swings, weight gain (particularly around hips and thighs), headaches, decreased libido, and sleep disturbances. Treatment approaches include addressing root causes, supporting progesterone production, and optimizing estrogen detoxification pathways.
How do you convert progesterone between ng/mL and nmol/L units?
Converting between progesterone units requires knowing the molecular weight of progesterone, which is 314.46 g/mol. To convert from ng/mL to nmol/L, multiply by 3.18 (the conversion factor derived from 1000/314.46). To convert from nmol/L to ng/mL, divide by 3.18. For example, a progesterone level of 15 ng/mL equals approximately 47.7 nmol/L. Similarly, estradiol conversions use its molecular weight of 272.38 g/mol: multiply pg/mL by 3.671 to get pmol/L, or divide pmol/L by 3.671 to get pg/mL. These conversions are essential because laboratories in different countries use different unit systems, with ng/mL being common in the United States and nmol/L being standard in many European and Australian laboratories.
When should the progesterone to estrogen ratio be tested during the menstrual cycle?
The timing of blood draws is critical for meaningful interpretation of the Pg/E2 ratio. For assessing luteal phase adequacy and ovulation confirmation, blood should be drawn 7 days after ovulation, which corresponds to approximately day 21 of a 28-day cycle. This is when progesterone reaches its peak concentration during the luteal phase. For women with irregular cycles, ovulation can be confirmed through basal body temperature tracking or urinary LH surge detection, with blood drawn 7 days after the confirmed ovulation day. Some clinicians recommend testing on multiple days (days 19, 21, and 23 for a 28-day cycle) to capture the progesterone peak. Fasting morning samples are preferred for consistency, as both hormones have mild diurnal variation.
How does the progesterone to estrogen ratio change during perimenopause and menopause?
During perimenopause (typically ages 40-55), the Pg/E2 ratio often decreases significantly because progesterone production declines more rapidly and earlier than estrogen. As ovulation becomes less frequent and less reliable, progesterone drops because it is primarily produced by the corpus luteum after ovulation. Meanwhile, estrogen levels may actually fluctuate wildly, sometimes spiking to very high levels before eventually declining. This creates a prolonged state of relative estrogen dominance that may explain many perimenopausal symptoms including heavy periods, breast tenderness, and mood changes. After menopause, both hormones reach very low levels, but the ratio becomes less clinically relevant. Hormone replacement therapy dosing aims to maintain a balanced ratio to minimize risks.